Paperpal Prime Logo

Research and Practice in Thrombosis and Haemostasis : Impact Factor & More

eISSN: 2475-0379pISSN: 2475-0379
JournalOpen Access

Key Metrics

CiteScore
5.8
Impact Factor
< 5
SJR
Q4Hematology
SNIP
1.41
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Research and Practice in Thrombosis and Haemostasis

Research and Practice in Thrombosis and Haemostasis Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Article-by-article
Article Processing ChargesUSD 2250
Publication Time7
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorInternational Society on Thrombosis and Haemostasis
FrequencyArticle-by-article
Publication Start Year2017
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 7
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Research and Practice in Thrombosis and Haemostasis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Research and Practice in Thrombosis and Haemostasis

Temporal validation of the electronic health record cancer-associated thrombosis model in patients with low bleeding risk
  • 14 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Biological clocks and blood clots in space: circadian disruption-induced modulation of thrombosis risk
  • 14 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Prognostic value of von Willebrand factor and ADAMTS-13 in patients with sepsis-induced coagulopathy
  • 14 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Identification of a protein S\u2013binding site in the C2 domain of factor VIII light chain
  • 13 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Circulating extracellular vesicle tissue factor activity is associated with disseminated intravascular coagulation in 2 cohorts of patients with sepsis
  • 13 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
In vitro comparison of the effects of abelacimab, dalteparin, and apixaban on catheter-induced clotting and thrombin generation
  • 13 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Temporal validation of the electronic health record cancer-associated thrombosis model in patients with low bleeding risk
  • 14 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Biological clocks and blood clots in space: circadian disruption-induced modulation of thrombosis risk
  • 14 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Prognostic value of von Willebrand factor and ADAMTS-13 in patients with sepsis-induced coagulopathy
  • 14 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Identification of a protein S\u2013binding site in the C2 domain of factor VIII light chain
  • 13 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
Circulating extracellular vesicle tissue factor activity is associated with disseminated intravascular coagulation in 2 cohorts of patients with sepsis
  • 13 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis
In vitro comparison of the effects of abelacimab, dalteparin, and apixaban on catheter-induced clotting and thrombin generation
  • 13 Jul 2026
  • Research and Practice in Thrombosis and Haemostasis

FAQs on Research and Practice in Thrombosis and Haemostasis